Lee Schwamm, M.D.

Physician Investigator (NonCl)
Neurology, Mass General Research Institute
Senior Lecturer on Neurology, Part-time
Harvard Medical School
acute ischemic stroke; brain ischemia; fibrinolytic agents; intracerebral hemorrhage; intravenous thrombolysis; ischemic attack transient; stroke; telehealth; telestroke; thrombolytic therapy; tissue plasminogen activator

Dr. Schwamm graduated from Harvard Medical School and completed his neurology residency and subsequent NeuroCritical Care and Vascular Neurology fellowships at Massachusetts General Hospital. He is Professor of Neurology at Harvard Medical School, and C. Miller Fisher Chair of Vascular Neurology at MGH, where he is Executive Vice Chairman of Neurology, Chief of the Stroke Division, and Director of the Comprehensive Stroke Center and the Center for TeleHealth.

He serves as co-chair of the Innovation Council, and Chair of Stroke Quality for Partners Healthcare. He is the author of >300 peer-reviewed articles, and chaired many of the current practice guidelines for stroke and telehealth-enabled care delivery.

He has received numerous awards for innovation, leadership and advocacy in the field of stroke. His pioneering work includes leadership of the first large-scale and longest-running national TeleStroke Network, currently serving 52 hospitals in 7 states, and the AHA’s Get With the Guidelines-Stroke, the world largest stroke registry with >4.7 million patient records.

His clinical interests are in cerebrovascular diseases, telehealth and clinical trials, and he is a recognized leader in the fields of acute stroke treatment, stroke systems of care, health services research, and telehealth.

His research has been funded by numerous organizations, including Harvard, MIT, NIBIB, NINDS, CDC, PCORI AHRQ, HRSA and the Department of the Army. He is a long-standing and dedicated AHA volunteer who currently chairs or co-chairs the Quality Oversight Committee, Healthcare Accreditation Science Committee, Brain Health & Healthy Aging Taskforce, and Mission-Lifeline Stroke and serves on numerous other scientific and AHA Board subcommittees.

Dr. Schwamm is the author of over 300 publications in the field of cerberovascular disease, with works published in the major academic journals in the field. He serves on the editorial boards of the journals Stroke and Neurocritical Care.

Dr. Schwamm’s research has been funded by numerous sources, including Harvard University/Harvard Medical School, Massachusetts Institute of Technology, Aetna Foundation, Dana Foundation, Center for Integration of Medicine and Innovative Technology, National Institute of Biomedical Imaging and Bioengineering, National Institute of Neurological Disorders and Stroke, Centers for Disease Control and Prevention, Patient-Centered Outcomes Research Institute, Agency For Healthcare Research And Quality, Health Resources and Services Agency, Massachusetts Department of Public Health, and US Department of the Army.